We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FFBC:NASDAQFirst Financial Bancorp. Analysis

Data as of 2026-08-25 - not real-time

$32.76

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

First Financial Bancorp. trades at $32.76, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has lost 4.3% over the past 30 days. With RSI at 37.5 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near $32.58 and resistance around $34.86.
Multiples put this in undervalued territory: 11.6 times earnings against the sector's 17.0. The average analyst target implies 14.7% above today's level. Revenue is growing at 16.5% on a 29.9% profit margin. The 3.06% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 23.2%, a beta of 0.64 and a maximum drawdown of 15.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.

Top Market Events

Detailed price information for First Finl Bncp Oh FFBC-Q from The Globe and Mail including charting and trades.Detailed price information for First Finl Bncp Oh FFBC-Q from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 29.42
  • MACD momentum is negative
  • RSI at 37.5 is in neutral territory

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 11.6 versus sector average of 17.0
  • Trading above the 200-day average of 29.42
  • Analyst targets imply +14.7% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 11.6 versus sector average of 17.0
  • Analyst targets imply +14.7% versus the current price
  • Profit margin of 29.9% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth16.50%
Profit Margin29.93%
P/E Ratio11.6
ROE10.29%
ROA1.39%
P/B Ratio1.2
Op. Cash Flow$792.3M
Industry P/E17.0

Technical Analysis

TrendNeutral
RSI37.5
Support$32.58
Resistance$34.86
MA 20$33.75
MA 50$33.79
MA 200$29.42
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14

Valuation

Fair Value$130.47
Target Price$37.57
Upside/Downside14.69%
GradeUndervalued
TypeValue
Dividend Yield3.06%

Risk Assessment

Beta0.64
Volatility23.17%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.